Development and Validation Study of the Prognostic Impact of Deep Learning-Determined Myxoid Stroma After Neoadjuvant Chemotherapy in Patients with Esophageal Squamous Cell Carcinoma.

Abstract

Authors

• Keita Kouzu
  Department of Surgery, National Defense Medical College, Saitama, Japan.
• Hironori Tsujimoto
  Department of Surgery, National Defense Medical College, Tokorozawa, Japan.
• Yu Imamura
  Department of Esophageal Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
• Yoshiki Kajiwara
  Department of Surgery, National Defense Medical College, Saitama, Japan.
• Ines P Nearchou
  School of Medicine, University of St Andrews, North Haugh, St Andrews, Fife, KY16 9TF, UK.
• Takahiro Einama
  Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
• Manabu Takamatsu
  Division of Pathology, The Cancer Institute; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. Electronic address: manabu.takamatsu@jfcr.or.jp.
• Ikumi Haraguchi
  Cancer Precision Medicine Center, Cancer Institute of Japanese Foundation for Cancer Research, Koto, Tokyo, Japan.
• Takanori Watanabe
  Department of Pathology and Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan.
• Hiroyuki Horiguchi
  Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan.
• Yoji Kishi
  Department of Surgery, National Defense Medical College, Saitama, Japan.
• Hitoshi Tsuda
  Department of Pathology and Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan.
• Masayuki Watanabe
• Hideki Ueno
  Department of Surgery, National Defense Medical College, Saitama, Japan.

Keywords

External Resources